Microsoft word - kar_publikationen2004.doc

Kardiologie, UniversitätsSpital Zürich Publikationen 2004

Published Original Reviews
Nitric oxide gene transfer inhibits biological features of bypass graft disease in the Tanner F.C., Largiadèr T., Greutert H., Yang Z., Lüscher T.F.
J. Thorac. Cardiovasc. Surg. 127, 20-26, 2004. Oxidative stress-associated vascular aging is independent of the protein kinase Bachschmid M., van der Loo B., Schüler K., Labugger R., Thurau S., Kilo J., Hölz
R., Lüscher T.F., Ulrich V.
Arch. Gerontol. Geriatr. 38, 181-190, 2004. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, Anand I.S., McMurray J., Cohn J.N., Konstam M.A., Notter T., Quitzau K.,
Ruschitzka F.T., Lüscher T.F. on behalf of the EARTH investigators.
OR-4 Selective inhibition of Protein Kinase Cß prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells. Kouroedov A., Cosentino F., Eto M., Joch H., Volpe M., Lüscher T.F.
OR-5 Systemic inhibition of nitric oxide synthase unmasks neural constraint of maximal Kaufmann P.A., Rimoldi O., Gnecchi-Ruscone T., Bonser R.S., Lüscher T.F.,
Camici P.G.

Kardiologie, UniversitätsSpital Zürich sleep-related breathing disorders by visual analysis of transthoracic impedance signals in pacemakers.
Scharf C., Cho Y.K., Bloch K.E., Brunckhorst C.B., Duru F., Balaban K., Foldvary
N., Liu L., Burgess R.C., Candinas R., Wilkoff B.L.
β-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments. Koepfli P., Wyss C.A., Namdar M., Klainguti M., von Schulthess G.K., Lüscher
T.F., Kaufmann P.A.
Effect of rheumatoid arthritis or systemic Lupus Erythematosus on the risk of first-time Fischer L.M., Schlienger R.G., Matter C.M., Jick H., Meier C.R.
Molecular imaging of atherosclerotic plaques by using a human antibody against the Matter C.M. *, Schuler P.K. *, Alessi P., Meier P., Ricci R., Zhang D., Halin C.,
Castellani P., Zardi L., Hofer C.K., Montani M., Neri D., Lüscher T.F.
Circulation Research 95, 1225-1233, 2004. *equal contribution OR-10 Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in Ricci R., Sumara G., Sumara I., Rozenberg I., Kurrrer M.O., Akhmedov A.,
Hersberger M., Eriksson U., Eberli F.R., Becher B., Borén J., Chen M., Cybulsky
M.I., Moore K.J., Freeman M.W., Wagner E.F., Matter C.M. *, Lüscher T.F. *.
Science 306, 1558-1561, 2004. *equal contribution OR-11 Plasma homocysteine and restenosis after femoropopliteal angioplasty. Kovacevic T., van der Loo B., Amann-Vesti B., Rousson V., Koppensteiner R.
Kardiologie, UniversitätsSpital Zürich OR-12 C-Reactive Protein and red cell aggregation correlate with late venous function Krieger E., van der Loo B., Amann-Vesti B., Rousson V., Koppensteiner R.
OR-13 CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid Koepfli P., Hany T.F., Wyss C.A., Namdar M., Burger C., Konstantinidis A.V.,
Berthold T., von Schulthess G.K., Kaufmann P.A.
OR-14 Ventricular mapping during atrial and right ventricular pacing: relation of electrogram parameters to ventricular tachycardia reentry circuits after myocardial infarction. Brunckhorst C.B., Delacretaz E., Soejima K., Jackman W.M., Nakagawa H., Kuck
K.H., Ben-Haim S.A., Seifert B., Stevenson W.G.
J. Interv. Card. Electrophysiol. 11(3), 183-191, 2004. OR-15 Identification of the ventricular tachycardia isthmus after infarction by pace mapping. Brunckhorst C.B., Delacretaz E., Soejima K., Maisel W.H., Friedman P.L.,
Stevenson W.G.
OR-16 ICD therapies in patients with coronary artery disease: incidence of adequate ICD Brunckhorst C.B., Holzmeister J., Scharf C., Binggeli C., Hellermann J.P., Duru F.
OR-17 Deleterious effect of coronary brachytherapy on vasomotor response to exercise. Togni M., Windecker S., Wenaweser P., Tueller D., Kaiser A., Maier W., Meier
B., Hess O.M.
OR-18 Percutaneous coronary interventions in Europe 1992-2001. Togni M., Balmer F., Pfiffner D., Maier W., Zeiher A.M., Meier B.
Kardiologie, UniversitätsSpital Zürich PPARγ-agonist has synergistic effect on plaque regression in combination with simvastatin. In vivo study by high-resolution MRI. Corti R., Osende J.I., Fallon J.T., Fuster V., Mizsei G., Jneid H., Wright S.D.,
Chaplin W.F., Badimon J.J.

J. Am. Coll. Cardiol. 43, 464-473, 2004. OR-20 Effect of percutaneous transluminal angioplasty (PTA) and endovascular brachytherapy (EVBT) on vascular remodeling of human femoropopliteal artery by noninvasive MRI. Wyttenbach R., Gallino A., Alerci M., Mahler F., Cozzi L., Di Valentino M.,
Badimon J.J., Fuster V., Corti R.
OR -21 Interventions cardiaques percutanées en Suisse en 2001. Schlüter L., Rickli H., Vuillomenet A., Chatelain P., Eberli F., Meier B., Eeckhout
Kardiovaskuläre Medizin 7(2), 61-70, 2004. OR-22 Impact of clopidogrel in coronary artery bypass grafting. Engelberger L., Faeh B., Berdat P.A., Eberli F.R., Meier B., Carrel T.
Eur. J. Cardiothorac. Surg. 26, 96-101, 2004. OR-23 Deletion of p66 shc gene protects against age-related endothelial dysfunction. Francia P., Delli Gatti C., Bachschmid M., Martin-Padura I., Savoia C., Migliaccio
E., Pelicci P.G., Schiavoni M., Lüscher T.F., Volpe M., Cosentino F.
OR -24 Pharmacological mechanisms of clinically favorable properties of a selective Kouroedov A., Cosentino F., Luscher T.F.
Cardiovascular Drug Reviews 22(3), 155-168, 2004. OR-25 Die wissenschaftliche Produktivität in der Schweiz - eine bibliometrische Analyse am Beispiel kardiologischer und onkologischer Forscher. Fahrni J., Hellermann J.P., Lüscher T.F.
Kardiovaskuläre Medizin 7, 238-246, 2004. Kardiologie, UniversitätsSpital Zürich OR-26 Trends in heart failure incidence and survival in a community-based population. Roger V.L., Weston S.A., Redfield M.M., Hellermann J.P., Kilian J., Yawn B.P.,
Jacobsen S.J.
subclavian artery perfusion for repair of acute type A dissection. Reuthebuch O., Schurr U., Hellermann J.P., Pretre R., Kunzli A., Lachat M.,
Turina M.I.
European Journal of CardioThoracic Surgery, 26(3), 592-598, 2004. assessment. A comparison with thermodilution. Bettex B.A., Hinselmann V., Hellermann J.P., Jenni R., Schmid E.R.
OR-29 Aberrant tendinous chors with tethering of the tricuspid leaflets: a congenital anomaly Kobza R., Kunz D.J. *, Oechslin E. *, Pretre R., Zuber M., Vogt P., Jenni R.
* equal contributions from these authors OR-30 Novel gene locus for autosomal dominant left ventricular noncompaction maps to Sasse-Klaassen S., Probst S., Gerull B., Oechslin E., Nurnberg P., Heuser A., Jenni
R., Hennies H.C., Thierfelder L.
OR-31 A novel in vivo procedure for volumetric flow measurements. Jenni R., Matthews F., Aschkenasy S.V., Lachat M., van der Loo B., Oechslin E.,
Namdar M., Jiang Z., Kaufmann P.A.
Ultrasound. Med. Biol. 30, 633-637, 2004. OR-32 Idiopathic enlargement of the right atrium: 23 year follow up of a familial cluster and Kurz D.J., Oechslin E., Kobza R., Jenni R.
Kardiologie, UniversitätsSpital Zürich OR-33 Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Zuber J.P., Calmy A., Evison J.M., Hasse B., Schiffer V., Wagels T., Nuesch R.,
Magenta L., Ledergerber B., Jenni R., Speich R., Opravil M.; Swiss Cohort Study
OR-34 Gated 99mTc-Tetrofosmin SPECT for discriminating infarct in fixed myocardial Fleischmann S., Koepfli P., Namdar M., Wyss C.A., Jenni R., Kaufmann P.A.
OR-35 Regional myocardial ischemia in hypertrophic cardiomyopathy: impact of myectomy. Jorg-Ciopor M., Namdar M., Turina J., Jenni R., Schwitter J., Turina M., Hess
O.M., Kaufmann P.A.
J. Thorac. Cardiovasc. Surg. 128, 163-169, 2004. OR-36 ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy). Cura F.A., Roffi M., Pasca N., Wolski K.E., Lincoff A.M., Topol E.J., M.S. for The
Global Use of Strategies to open Occluded Arteries (GUSTO) V Investigators. OR-37 Severe carotid stenosis: the impact of ipsilateral stenting on Doppler-defined Sachar R., Yadav J.S., Roffi M., Cho L., Reginelli J.P., Abou-Chebl A., Bhatt D.L.,
Bajzer C.T.

J. Am. Coll. Cardiol. 43, 1358-1362, 2004. OR-38 Feasibility of simultaneous bilateral carotid artery stenting. Chen M.S., Bhatt D.L., Mukherjee D., Chan A.W., Roffi M., Kapadia S.R., Ziada
K.M., Chew D.P., Bajzer C.T., Yadav J.S.
Catheter. Cardiovasc. Interv. 61, 437-442, 2004. Kardiologie, UniversitätsSpital Zürich observer-dependence, and accuracy of measurements of left ventricular ejection fraction using 4-channel MDCT. Boehm T., Alkadhi H., Roffi M., Desbiolles L.M., Willmann J.K., Marincek B.,
Wildermuth S.
OR-40 Shear stress-dependent platelet function after LDL cholesterol apheresis. Spieker L.E., Ruschitzka F.T., Badimon J.J., Noll G., Corti R.
OR-41 Endothelial and smooth muscle cell dysfunction in human atherosclerotic radial artery: implications for coronary artery bypass grafting. Stähli B.E., Caduff R.F., Greutert H., Kipfer B., Carrel T.P., Tanner F.C.
J. Cardiovasc. Pharmacol. 43, 222-226, 2004. improves endothelial function in rheumatoid Arthritis. Hermann F., Forster A., Chenevard R., Enseleit F., Corti R., Spieker L.E., Frey D.,
Hermann M., Riesen W., Neidhart M., Michel B.A., Hellermann J.P., MSc, Gay
R.E., Lüscher T.F., Gay S., Noll G., Ruschitzka F.T.

OR-43 Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3- Hydroxy-3-Methylglutaryl Coenzyme A reductase inhibitor, but does not depend on Kilic E., Kilic Ü., Matter C.M., Lüscher T.F., Bassetti C., Hermann D.M.
OR-44 Diagnostic yield of the implantable loop recorder to detect the mechanism of syncope – a single center long term experience of a tertiary care center. Brunckhorst C.B., Lemola K., Holzmeister J., Scharf C., Altwegg S., Binggeli C.,
Hellermann J.P., Enseleit F., Duru F.

OR-45 Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hermann M., Shaw S., Kiss E., Camici P.G., Buhler N., Chenevard R., Lüscher T.F.,
Grone H.J., Ruschitzka F.T.
Kardiologie, UniversitätsSpital Zürich OR-46 Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in Wyss C.A., Koepfli P., Namdar M., Siegrist P.T., Luscher T.F., Camici P.G.,
Kaufmann P.A.
Eur. J. Nucl. Med. Mol. Imaging. 32(1), 84-91, 2005. OR-47 Assessment of the long-term reproducibility of baseline and Dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. Jagathesan R., Kaufmann P.A., Rosen S.D., Rimoldi O.E., Turkeimer F., Foale R.,
Camici P.G.
OR-48 Tecture analysis in digitally acquired echocardiographic images: the effect of JPEG Aschkenasy S.V., Muntwyler J., van der Loo B., Oechslin E., Jenni R.
OR-49 Real-time MR-guided endomyocardial local delivery. Corti, R., Badimon J.J., Mizsei G., Macaluso F., Lee M., Licato P., Fuster V.,
Sherman W.
OR-50 Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Wenaweser P., Rey C., Eberli F.R., Togni M., Tüller D., Locher S., Remondino A.,
Seiler C., Hess O.M., Meier B., Windecker S.
OR-51 Does shear stress modulate both plaque progression and regression in the thoracic Wentzel J.J., Corti R., Fayad Z.A., Wisdom P., Macaluso F., Winkelman M.O.,
Fuster V., Badimon J.J.
Kardiologie, UniversitätsSpital Zürich implantierbarem Loop Recorder: Langzeiterfahrung eines Brunckhorst C.B., Lemola K., Holzmeister J., Scharf C., Altwegg S., Binggeli C.,
Hellermann J.P., Enseleit F., Duru F.
Schweiz. Rundsch. Med. Prax. (in press), 2005. OR-53 Predictors of adverse outcome in patients with arrhythmogenic right ventricular Lemola K., Brunckhorst C.B., Helfenstein U., Oechslin E., Jenni R., Duru F.
OR-54 Induction ovens and electromagnetic interference: what is the risk for patients with implantable cardioverter defibrillators? Binggeli C., Rickli H., Ammann P., Brunckhorst C.B., Hufschmid U., Luechinger
R., Duru F.
J. Cardiovasc. Electrophysiol. (in press), 2005. OR-55 Impact of changing activation sequence on bipolar electrogram amplitude for voltage mapping of left ventricular infarcts causing ventricular tachycardia. Brunckhorst C.B., Delacretaz E., Soejima K., Maisel W.H., Friedman P.L.,
Stevenson W.G.
J. Interv. Card. Electrophysiol. (in press), 2005. OR-56 Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting van der Loo B., Kovacevic T., Krieger E., Banyai S., Banyai M., Amann-Vesti B.R.,
Jagacic D., Rousson V., Koppensteiner R.
Clin. Hemorheol. Micro. (in press), 2005. OR-57 Discontinuation of nonsteroidal anti-inflammatory drugs is associated with increased Fischer L.M., Schlienger R.G., Matter C.M., Jick H., Meier C.R.
Kardiologie, UniversitätsSpital Zürich OR-58 Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum Amyloid A, but decreased C-Reactive Protein. Maier W., Altwegg L.A., Corti R., Gay S., Hersberger M., Maly F.E., Sütsch G.,
Roffi M., Neidhart M., Eberli F.R., Tanner F.C., Gobbi S., von Eckardstein A.,
Lüscher T.F.
OR-59 Current use of non-steroidal anti-inflammatory drugs and the risk of acute myocardial Fischer L.M., Schlienger R.G., Matter C.M., Jick H., Meier C.R.
OR-60 Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun Steffel J., Hermann M., Greutert H., Gay S., Lüscher T.F., Ruschitzka F.T., Tanner
OR-61 In vivo heating of pacemaker leads during magnetic resonance imaging. Luechinger R., Zeijlemaker V.A., Pederson E.M., Mortensen P., Falk E., Duru F.,
Candinas R., Boesiger P.
Overview article
OA-01 Brunckhorst C.B., Holzmeister J., Scharf C., Binggeli C., Hellermann J.P., Duru F.
Schweiz. Rundsch. Med. Prax. 93, 803-815, 2004. OA-02 Binggeli C., Candinas R., Brunckhorst C.B.
OA-03 Brunckhorst C.B., Delacretaz E.
Ventricular tachycardia – etiology, mechanisms and therapy. Kardiologie, UniversitätsSpital Zürich OA-04 Brunckhorst, C.B.
Schweiz. Rundsch. Med. Prax. 93 (39), 1582-3, 2004. OA-05 Lemola K., Duru F.
J. Cardiovasc. Electrophysiol. 15, 1222-1223, 2004. OA-06 Cosentino F., Egidy Assenza G.
OA-07 van der Loo B., Koppensteiner R., Lüscher T.F.
Wie altern Gefässe? Mechanismen und klinische Implikationen. OA-08 Riesen W.F., Darioli R., Noll G.
Lipid-lowering therapy: strategies for improving compliance. Curr. Med. Res. Opin. 20(2), 165-173, 2004. OA-09 Lüscher T.F., Corti R.
OA-10 Spieker L.E., Ruschitzka F.T., Lüscher T.F., Noll G.
HDL and inflammation in atherosclerosis. Curr. Drug. Targets. Immune. Endocr. Metabol. Disord. 4(1), 51-57, 2004. OA-11 van der Loo B.
Mechanismen der Gefässalterung und klinische Implikationen. OA-12 Kaufmann P.A., Camici P.G.
Myocardial blood flow measurement by PET: technical aspects and clinical applications. Kardiologie, UniversitätsSpital Zürich OA-13 Worthley M.I., Corti R., Worthley S.G.
Vasopeptidase inhibitors: will they have a role in clinical practice? Br. J. Clin. Pharmacol. 57, 27-36, 2004. OA-14 Corti R., Fuster V.
Should standard medical therapy for angina include a statin? OA-15 Corti R., Hutter R., Badimon J.J., Fuster V.
Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J. Thrombosis and Thromboslysis 17, 35-44, 2004. Luechinger R., Duru F., Candinas R., Boesiger P.
Safety considerations for magnetic resonance imaging of pacemaker and ICD patients. OA-17 Corti R., Spieker L.E., Mach F., Erne P., Moccetti T., Beer J., Urban P., Buser P.,
Rickenbacher P., Eberli F.R., Sigwart U., Hunziker P., Angehrn W.,
Kappenberger L., Bertel O., Windecker S., Clemetson K.J., Meier B., Lüscher T.F.

Plättchenhemmung durch Thienopyridine beim akuten Koronarsyndrom und nach perkutaner koronarer Intervention – praktische Empfehlungen. Kardiovaskuläre Medizin 7, 159-173, 2004. OA-18 Largiadèr T., Eberli F.R.
Klappenvitien in der ärztlichen Praxis. OA-19 Eberli F.R.
Guidelines and metabolic approach to acute coronary syndrome. OA-20 Eberli F.R.
Stunned myocardium – an unfinished puzzle. Cardiovascular Research 63, 189-191(editorial), 2004. Kardiologie, UniversitätsSpital Zürich OA-21 Brunschwig T., Eberli F.R., Herren T.
Mechanische Komplikationen bei akutem Myokardinfarkt. OA-22 Roffi M., Oechslin E.
Kardiale Indikationen für orale Antikoagulation [Cardiac indications for oral Schweiz. Rundsch. Med. Prax. 93, 1549-1555, 2004. OA-23 Osterwalder J., Gerecke P., Oechslin E., von Planta M.
Nouvelles directives ACLS 2000: un aperçu. Schweizerische Ärztezeitung 85, 2399-2408, 2004. OA-24 Attenhofer Jost C.H., Lüscher T.F., Oechslin E., Turina J., Jenni R., Speich R.
Schweiz. Med. Forum. 4(3), 49-55, 2004. OA-25 Oechslin E.
Hematological management of the cyanotic adult with congenital heart disease. Int. J. Cardiol. 97 Suppl. 1, 109-115, 2004. OA-26 Roffi M.
Impact of diabetes on cute coronary syndromes. Kardiovaskuläre Medizin 7, 325-330, 2004. OA-27 Roffi M., Oechslin E.
Cardiac indications for oral anticoagulation. OA-28 Roffi M., Topol E.J.
Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation OA-29 Roffi M.
Percutaneous intervention of saphenous vein grafts. ACC Current Journal Review 13, 45-48, 2004. Kardiologie, UniversitätsSpital Zürich OA-30 Hürlimann D., Enseleit F., Ruschitzka F.T.
Rheumatoid arthritis, inflammation, and atherosclerosis. OA-31 Hermann F., Ruschitzka F.T., Schiffrin E.L.
Clinical trials report. The sweet secret of dark chocolate. OA-32 Kobza R., Candinas R., Hindricks G., Kottkamp H., Livas G., Duru F.
Die elektrophysiologische Untersuchung: Vorgehensweise und Indikationen. Schweiz. Rundsch. Med. Prax. (in press), 2005.
Case Reports/ Letters
CR-1 Karadag B., Spieker L.E., Schwitter J., Ruschitzka F.T., Lüscher T.F., Noll G., Corti
Lyme carditis restitutio ad integrum documented by cardiac magnetic resonance Maile S., Kunz M., Oechslin E., Zünd G., Rahn M., Lachat M.L., Turina M.
Intractable ventricular tachycardia and bridging to heart transplantation with a non- pulsatile flow assist device in a patient with isolated left-ventricular non-compaction. Heart Lung. Transplant. 23, 147-149, 2004. Spieker L.E., Hufschmid U., Oechslin E., Jenni R.
Double aortic and pulmonary valves: an artifact generated by ultrasound refraction. J. Am. Soc. Echocardiogr. 17, 786-787, 2004. Thierfelder L., Sasse-Klaassen S., Gerull B., Jenni R., Oechslin E.
Response to correspondence by Dr. Finsterer and Dr. Stollberger: Heterogenous myopathic background of left ventricular hypertrabeculation/noncompaction. Kardiologie, UniversitätsSpital Zürich Mueller J.P., Reuthebuch O., Jenni R., Turina M.
Pseudoaneurysma of the left ventricle near the non-coronary sinus valsalvae after aortic Eur. J. Cardiothorac. Surg. 25, 283, 2004. Spieker L., Maier W., Jenni R.
Eine Frau mit einer intramyokardialen Verkalkung. Kardiovaskuläre Medizin 7, 218-220, 2004. Spieker L.E., Jenni R.
An apparently immobile mitral valve prothesis leaflet. J. Am. Soc. Echocardiogr. 17, 905, 2004. Minder S., Fischler M., Muellhaupt B., Zalunardo M.P., Jenni R., Clavien P.A.,
Speich R.
Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary Dorschner L., Speich R., Ruschitzka F.T., Seebach J.D., Gallino A.
Everolimus-induced drug fever after heart transplantation. CR-10 Duru F.
Comparison of the specificity of implantable dual chamber defibrillator detection Pacing. Clin. Electrophysiol. (in press), 2005. CR-11 Abay M., Wyss C.A., Eberli F.R., Roffi M., Oechslin E., Jenni R.
Severe stenosis of a bovine jugular vein graft in pulmonary position. J. Am. Soc. Echocardiogr. (in press), 2005. CR-12 Duru F., Brunckhorst C.B., Scharf C., Luechinger R.
Automatic impedance monitoring and patient alert feature in implantable cardioverter defibrillators: Being alert for the unexpected! J. Cardiovasc. Electrophysiol. (in press), 2005. Kardiologie, UniversitätsSpital Zürich R. Jenni.
From clinical observation to the discovery of a new disease: Two decades in search of isolated non-compaction of the myocardium in adults, M. Roffi, B. Meier, E.J. Topol, eds.
CVMstat®. A comprehensive handheld computer-based approach to cardio vascular medicine, 1st Edition, Handheldmed Inc., Little Rock, Arkansas, USA, 2004.
Book Chapters
NEP/ACE inhibitors: experimental and clinical aspects. Corti R., Ruschitzka F.T., Lüscher T.F.
In: Handbook of experimental pharmacology 163/II, Angiotensin. T.Unger, B.A. Schölkens eds., Springer, Berlin – Heidelberg – New York, 2004, pp. 519-544. Hypertension and blood vessels: from diagnosing vascular events to the assessment of Spieker L.E., Lüscher T.F.
In: Handbook of hypertension, vo. 22, hypertension in the twentieth century: concepts and achievements. W.H.Birkenhäger, J.I.S. Robertson, A. Zanchetti eds., Elsevier, Percutaneous coronary revascularization in diabetic patients. Cosentino F., Loufti M., Roffi M., Lüscher T.F., Marco J.
In: The Paris course on revascularization. J. Marco, P. Serruys, G. Biamino, J. Fadajet, M.C. Morice, W. Wijns, B. de Bruyne, A. Vahanian, B. Katzen, F.Mahler, M. van Coronary thrombosis – local and systemic factors. Corti R., Badimon L., Fuster V., Badimon J.J.
In: Atherothrombosis and coronary artery disease, 2/e. V. Fuster, E.J. Topol, E.G. Nabel Lippincott Williams & Wilkins publication. 2004, pp. 475-485. Kardiologie, UniversitätsSpital Zürich Lüscher T. F., Noll G., Spieker L., Corti R., Pepine C.J.
In: Atherothrombosis and coronary artery disease, 2/e. V. Fuster, E.J. Topol, E.G. Nabel Lippincott Williams & Wilkins publication. 2004, pp. 599-621. Roffi M., Mukherjee D.
In: Manual of vascular diseases. S. Rajagopalan, E. Mohler, D. Mukherjee eds., Lippincott William and Wilkins, New York, USA, 1st edition , 2005, pp. 135-155. Roffi M., Schnyder G.
In: Guide to Peripheral and Cerebrovascular Intervention, 1st edition. D.L. Bhatt ed. Remedica publishing, London, UK, 2004, pp. 51-63. Eberli F.R.
In: CVMstat®. A comprehensive handheld-based approach to cardio vascular medicine. Handheldmed Inc. Little Rock, Arkansas, USA, 2004. Eberli F.R., Zimmerli M., Karadag B.
In: CVMstat®. A comprehensive handheld-based approach to cardio vascular medicine. Handheldmed Inc., Little Rock, Arkansas, USA, 2004. BC-10 ICD therapy in ventricular tachyarrhythmias and survived sudden cardiac death. Duru F., Brunckhorst C.B.
In: Proceedings of state of the art in atrial fibrillation and ventricular Tachyarrhythmias. Kardiologie, UniversitätsSpital Zürich Scharf C., Duru F.
In: Differenzialdiagnose innerer Krankheiten, 19. Auflage. W. Siegenthaler ed. In: Pharmacological therapies for peripheral vascular diseases. D. Mukherjee ed., Martin BC-13 Aortic, iliac, and common femoral interventions. Roffi M., Biamino G.
In: The manual of peripheral vascular intervention. J. Yadav, I. Casserly, R. Sachar eds., Lippincott Williams & Wilkins, Philadelphia, PA, USA (in print), 2005. Biamino G., Scheinert D., Schmidt A., Mahler F., Baumgartner I., Roffi, M.
In: The European Society textbook of cardiovascular medicine. J. Camm, T.F. Lüscher, P. Blackwell Publishing, Oxford, UK (in print), 2005.



dj gramann II EDUCATION 1989 B.F.A. North Carolina School of the Arts, Winston-Salem, North Carolina TEACHING EXPERIENCE Fall 2008 TH 5530 Costume Design for the Theatre College of Theatre Arts and Dance, University of Minnesota, Twin Cities Focused on design process, participants execute four design projects using four different methods of achieving their design. Each project use

A t t e n t i o n

A T T E N T I O N!!!! Final Examination of Behavioural Sicences 4th Years general medical students The final examination of behavioural sciences is the total examination which covers all the materials of psychology, bioethics, medical anthropology, medical sociology and behavioural medicine. In the written „ A ” exam 100 items in test form should be solved. All of t

Copyright © 2010-2014 Metabolize Drugs Pdf